POLICY AND PRACTICE REVIEWS article

Front. Pharmacol.

Sec. Ethnopharmacology

Volume 16 - 2025 | doi: 10.3389/fphar.2025.1580586

This article is part of the Research TopicNutraceuticals and Medicinal Plants for Preventive Health Care: Integrative Approaches from Ethnopharmacology to Regulatory Science and Applications in Human Health and DiseaseView all articles

Reevaluating the safety of chamomile poultices in ophthalmic care

Provisionally accepted
Tibor  RákTibor Rák*Adrienne  CsutakAdrienne Csutak
  • University of Pécs, Pécs, Hungary

The final, formatted version of the article will be published soon.

Introduction: German chamomile [Matricaria recutita L. (Asteraceae)] tea poultices are a common folk remedy in Central and Eastern Europe for treating eye inflammations such as blepharitis and conjunctivitis. This practice often precedes medical consultation and professional advice. Surprisingly, some healthcare professionals, including pharmacists, naturopaths, general practitioners, and pediatricians, recommend it as a primary treatment, particularly among the elderly. However, the ophthalmic use of chamomile lacks scientific validation, and the European Medicines Agency (EMA) and ophthalmic guidelines warn of potential allergic reactions, including life-threatening anaphylaxis.Methods: This review examines the origins and descriptions of herbal poultices, with a focus on chamomile, by analyzing data from Hungarian and international medical literature. The study highlights the unsanitary production and storage conditions, also the external application of chamomile teas, which increase the risk of infection and contamination.Results: The findings indicate that chamomile tea poultices pose significant health risks due to potential allergic reactions and microbiological contamination. The study underscores the lack of scientific evidence supporting the ophthalmic use of chamomile and the dangers associated with its application.Discussion: The implications of these findings are critical for healthcare professionals and guideline developers. The study calls for discontinuing chamomile-based ophthalmic therapies and emphasizes the need for evidence-based practices. Future research should focus on validating the safety and efficacy of herbal remedies and developing guidelines to protect public health.

Keywords: Chamomile, Matricaria recutita, ocular poultice, Conjunctivitis, Hypersensitivity, Herbal tea

Received: 20 Feb 2025; Accepted: 14 Apr 2025.

Copyright: © 2025 Rák and Csutak. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Tibor Rák, University of Pécs, Pécs, Hungary

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.